During the Annual Open Enrollment Period for Medicare prescription drug coverage (Part D), Medicare beneficiaries are given the opportunity to select a new plan for the upcoming year. The 2027 plan year’s open enrollment period is October 15 – December…
In December 2025, the Centers for Medicare & Medicaid Services (CMS) announced two major initiatives to expand access to obesity management medications for Medicare and Medicaid beneficiaries: the Medicare GLP-1 Bridge program and the BALANCE (Better Approaches to Lifestyle and…
Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant reforms aimed at reducing the financial burden of prescription drug costs for Medicare Part D beneficiaries. A new report from MAPRx, however, shows that as a larger share of liability…
Study Finds Popular Prescription Drug Benefit Program Faces Challenges A new report released today on Medicare Part D found the program is as popular and robust as ever, but faces challenges that could result in increased costs and limited access…
The Medicare Access for Patients Rx (MAPRx) Coalition, comprised of more than fifty-five beneficiary advocacy organizations, urges the Centers for Medicare and Medicaid Services (CMS) to reverse its proposed policy changes to the Medicare Part D six “protected classes.” Proposed…